Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahram Valamehr

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2025
A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escapeDan Lu, Hui-Yi Chu, Soo Park, et al.
Cell Reports. Medicine|June 20, 2025
iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumorsBi-Huei Yang, Alma Gutierrez, Angela Liao, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cellsQuirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Cell Stem Cell|July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapiesQuirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Blood|August 2, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemiaFrank Cichocki, Jodie P Goodridge, Ryan Bjordahl, et al.
Nature Biomedical Engineering|August 8, 2022
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cellsSjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Nature Biomedical Engineering|February 12, 2024
Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cellsSjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Cancer Research|August 10, 2017
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor ActivityFrank Cichocki, Bahram Valamehr, Ryan Bjordahl, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2025
A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escapeDan Lu, Hui-Yi Chu, Soo Park, et al.
Cell Reports. Medicine|June 20, 2025
iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumorsBi-Huei Yang, Alma Gutierrez, Angela Liao, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cellsQuirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Cell Stem Cell|July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapiesQuirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Blood|August 2, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemiaFrank Cichocki, Jodie P Goodridge, Ryan Bjordahl, et al.
Nature Biomedical Engineering|August 8, 2022
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cellsSjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Nature Biomedical Engineering|February 12, 2024
Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cellsSjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Cancer Research|August 10, 2017
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor ActivityFrank Cichocki, Bahram Valamehr, Ryan Bjordahl, et al.
Pageof 4